This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

PCC 2024 — Pharmaceutical Compliance Congress

NETWORKING BEGINS IN

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as a Hybrid Event
April 16-18, 2024The Ritz-Carlton, Tysons Corner | McLean, VA

Michelle Axelrod
Principal, Life Sciences Regulatory and Compliance at Porzio, Bromberg & Newman, P.C.
Speaker

Profile

Michelle Axelrod is a principal of Porzio, Bromberg & Newman P.C. in the Life Sciences Compliance and Regulatory Counseling team, a member of the firm's Management Committee, and a Board Member of Porzio Compliance Services, a wholly-owned subsidiary of the firm. Michelle has over 25 years of experience addressing legal and compliance issues impacting companies in the life sciences industry; 15 years as in-house counsel. Michelle advises pharmaceutical, biotech, and medical device clients on legal and compliance issues through all stages of development, from clinical stage through commercialization. She counsels on clinical trial related compliance matters, communications and recruitment matters, and on product commercialization and related sales, marketing and reimbursement activities, including fraud and abuse. She also advises on privacy matters and supports clients’ compliance initiatives, including conducting compliance assessments/audits, and developing and implementing compliance programs, policies/SOPs, training, and monitoring and auditing programs. Michelle also negotiates, drafts and reviews various types of agreements common to the life sciences industry.

Agenda Sessions

  • Clinical and R&D Compliance –Emerging Trends and New Risk Areas

    4:15pm